Patent · US Active

Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (HUTNFR1) antibody

US11028178B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignee

BALIOPHARMA AG · CH

Inventors

Heike Bantel · Hannover, DE
Klaus Pfizenmaier · Tiefenbronn, DE
Andreas Herrmann · Stuttgart, DE

Key dates

Filing date	Nov 27, 2018
Grant date	Jun 8, 2021
Priority date	—
Expiry date	Nov 27, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An antibody specifically recognizing human tumor necrosis factor 1 (hu TNFR1), for use in treating nonalcoholic steatohepatitis (NASH) and disease conditions associated thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.